EMAIL DIGESTS
Daily
Every morning
Weekly
Sunday recap
Droia Ventures is a specialist investor dedicated to making an impact and saving patient lives by investing in the most promising life science companies.
Protego Biopharma Lands $130 Million Oversubscribed Series B Financing
Protego Biopharma Raises $130M in Series B Financing
Protego Biopharma Secures $130M Series B Funding
Protego Biopharma Secures $130M Series B Funding Led by Novartis Venture Fund